Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX
Eriko Takatori,1 Tadahiro Shoji,1 Takashi Sawai,2 Akira Kurose,3 Toru Sugiyama11Department of Obstetrics and Gynecology, 2Department of Pathology, Iwate Medical University, Morioka, Japan; 3Department of Anatomic Pathology, Hirosaki University, Hirosaki, JapanBackground: Differences in the incidence...
Main Authors: | Takatori E, Shoji T, Sawai T, Kurose A, Sugiyama T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/analysis-of-the-antitumor-activity-of-gemcitabine-and-carboplatin-agai-a13690 |
Similar Items
-
Are platinum agents, paclitaxel and irinotecan effective for clear cell carcinoma of the ovary? DNA damage detected with γH2AX induced by anticancer agents
by: Takatori Eriko, et al.
Published: (2012-06-01) -
Antitumor effects of combined carboplatin and gemcitabine in canine transitional cell carcinoma
by: De Brito Galvao, Joao Felipe
Published: (2011) -
COMPARISON BETWEEN GEMCITABINE-CARBOPLATIN AND COMBINATION OF GEMCITABINE-CARBOPLATIN AND CELECOXIB IN UROTHELIAL CARCINOMA CELL APOPTOSIS
by: Widya Sakti Pratama, et al.
Published: (2019-01-01) -
Gemcitabine- Carboplatin Combination therapy for recurrent ovarian cancer: a prospective study
by: Modares Gilani M, et al.
Published: (2008-10-01) -
Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report
by: Takatori E, et al.
Published: (2014-01-01)